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7Porcine Extrahepatic Vascular Endothelial
Asialoglycoprotein Receptor 1 Mediates
Xenogeneic Platelet Phagocytosis In Vitro and in
Human-to-Pig Ex Vivo Xenoperfusion
Anjan K. Bongoni,1,2,3 David Kiermeir,3 Julie Denoyelle,1,3 Hansjörg Jenni,4 Christopher Burlak,5 Jörg D. Seebach,6
Esther Vögelin,3 Mihai A. Constantinescu,3 and Robert Rieben1,3
Background.Asialoglycoprotein receptor-1 (ASGR1) mediates capture and phagocytosis of platelets in pig-to-primate liver xe-
notransplantation. However, thrombocytopenia is also observed in xenotransplantation or xenoperfusion of other porcine organs
than liver. We therefore assessed ASGR1 expression as well as ASGR1-mediated xenogeneic platelet phagocytosis in vitro and
ex vivo on porcine aortic, femoral arterial, and liver sinusoidal endothelial cells (PAEC/PFAEC/PLSEC).Methods. Porcine fore-
limbs were perfused with whole, heparinized human or autologous pig blood. Platelets were counted at regular intervals. Pig
limb muscle and liver, as well as PAEC/PFAEC/PLSEC, were characterized for ASGR1 expression. In vitro, PAEC cultured on
microcarrier beads and incubated with non-anticoagulated human blood were used to study binding of human platelets and
platelet-white blood cell aggregation. Carboxyfluorescein diacetate succinimidyl ester–labeled human platelets were exposed to
PAEC/PFAEC/PLSEC and analyzed for ASGR1-mediated phagocytosis. Results. Human platelet numbers decreased from
102 ± 33 at beginning to 13 ± 6 103/μL (P < 0.0001) after 10 minutes of perfusion, whereas no significant decrease of platelets
was seen during autologous perfusions (171 ± 26 to 122 ± 95  103/μL). The PAEC, PFAEC, and PLSEC all showed similar
ASGR1 expression. In vitro, no correlation was found between reduction in platelet count and platelet-white blood cell aggrega-
tion. Phagocytosis of human carboxyfluorescein diacetate succinimidyl ester–labeled platelets by PAEC/PFAEC/PLSEC peaked
at 15 minutes and was inhibited (P < 0.05 to P < 0.0001) by rabbit anti-ASGR1 antibody and asialofetuin. Conclusions. The
ASGR1 expressed on aortic and limb arterial pig vascular endothelium plays a role in binding and phagocytosis of human platelets.
Therefore, ASGR1 may represent a novel therapeutic target to overcome thrombocytopenia associated with vascularized pig-to-
primate xenotransplantation.
(Transplantation 2015;99: 693–701)Xenotransplantation of porcine organs and cells mayhelp to expand the pool of available donor organs for
clinical transplantation. However, despite considerable prog-
ress over the past decades, immune responses and other bar-
riers prevent clinical application. The use of organs stemmingReceived 27 May 2014. Revision requested 10 June 2014.
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FIGURE 1. Platelet counts during ex vivo perfusion of porcine fore-
limbs with heparinized human or autologous pig blood. Forelimbs
amputated from large white pigs of both sexes, weighing 30 to
40 kg, were connected to an extracorporeal perfusion circuit, and then
xenogeneic or autologous perfusions were performed. Perfusate
blood samples were collected at regular time intervals and platelets
counted using a Sysmex analyzer. A, A rapid loss of platelet counts
was observed in xenogeneic, but not in autologous perfusions. The
inset shows the enlarged graph for the first 60 minutes of perfusion
with indication of significant differences between autologous versus
xenoperfusion (one-way ANOVA with Bonferroni correction for indi-
vidual time points; *P ≤ 0.05, **P ≤ 0.01). Xenogeneic perfusions
(xeno) (n = 8) and autologous perfusions (auto) (n = 6). B, Statistical
analysis was carried out for area under the curve of the whole
720 minutes perfusions using the unpaired 2-tailed Student t test
(**P ≤ 0.005). ANOVA, analysis of variance.
694 Transplantation ■ April 2015 ■ Volume 99 ■ Number 4 www.transplantjournal.comto a dysregulation of the coagulation system and eventually
to organ dysfunction.7
Thrombocytopenia has been observed previously in
pig-to-primate xenotransplantation models, especially in
pig-to-baboon liver transplantation8 and during ex vivo
porcine liver perfusion with human blood.9 Although initial
hepatic function, including coagulation, was proven to be satis-
factory, the development of thrombocytopenia is currently
precluding pig liver xenotransplantation, even as a “bridge”
to allotransplantation.10 Platelet activation and aggregation
are critical events that might precede the development of
thrombocytopenia and/or sequestration of platelets in xeno-
grafts.11 However, platelet phagocytosis by endothelial cells
through receptor-ligand interactions cannot be excluded.
Recently, it has been shown that porcine Kupffer cells and
liver sinusoidal endothelial cells (LSEC) bind and phagocy-
tose human platelets in ex vivo perfusion systems.12 Many
scavenger receptors have been reported on LSEC that fa-
cilitate the clearance of particulate, molecular, and cellu-
lar “waste” from the circulation,13 one of them being the
asialoglycoprotein receptor-1 (ASGR1). It functions as a
recycling receptor, which mediates capture and phagocyto-
sis of Galβ1-4– and GalNAcβ1-4–terminating glycopro-
teins.14,15 Other functions of ASGR1 that have been put
forward include clearance of asialoglycoproteins16 andCopyright © 2015 Wolters Kluwerapoptotic cells.17 Asialoglycoprotein receptor-1 may also
participate in cell-cell, cell-matrix, or intramatrix interac-
tions.18 The receptor is expressed on porcine Kupffer cells,
hepatocytes,19 and on porcine LSEC (PLSEC). Finally, ASGR1
on PLSEC mediates phagocytosis of human platelets.20
Asialoglycoprotein receptor-1–mediated human platelet bind-
ing depends on the availability of carbohydrate binding sites
on ASGR1 as well as exposed carbohydrate ligands on plate-
lets, such as terminal Galβ1-4 and GalNAcβ1-4 residues. Re-
cently, it has been shown that, compared to porcine platelets,
human platelets have 4 times more Galβ1-4GlcNAc and
GlcNAcβ1-4GlcNAc ligands for ASGR1.21
In summary, thrombocytopenia after liver xenotrans-
plantation and ex vivo xenoperfusion is a well-recognized
phenomenon. In contrast, little is known on platelet phago-
cytosis mediated by other endothelial sites. Here, we report
that ex vivo xenoperfusion of amputated porcine forelimbs
with human blood using extracorporeal perfusion22 leads
to an immediate loss of human platelets from circulation.
We therefore examined ASGR1 expression on porcine vascu-
lar endothelial cells (EC) including aortic EC (PAEC), femoral
arterial (PFAEC), and PLSEC. In addition, the role of ASGR1
for binding and phagocytosis of human platelets was tested
in vitro.
MATERIALS AND METHODS
Ex Vivo Perfusion Model
Forelimbs of nontransgenic, large white pigs of both sexes,
weighing 30 to 40 kg, were used to perform ex vivo perfusion
with 500 mL of whole, heparinized (Liquemin, 10,000 IU/
500mL) anticoagulated human blood (xenoperfusion) or au-
tologous blood (autologous perfusion), for up to 12 hours as
described by Bongoni et al.22 Biopsies and blood samples
were collected at regular time intervals and blood cell counts
performed using an automated hematology analyzer (Sysmex
KX21N; Sysmex Suisse AG, Horgen, Switzerland) to mea-
sure changes in platelet counts.
Endothelial Cell Isolation and Culture
Porcine vascular EC (PAEC and PFAEC) were isolated
using a previously described method.23 The PLSEC isolation
from porcine liver was performed according to a previously
described method.20,21
Platelet Isolation and Carboxyfluorescein Diacetate
Succinimidyl Ester Labeling
Freshly isolated human platelets were labeledwith carboxy-
fluorescein diacetate succinimidyl ester (CFSE) usingCellTrace
CFSE Cell Proliferation Kit (Life Technologies) according to
manufacturer's protocols.
Immunofluorescence
Porcine ECs on 8-well Lab-Tek chamber slides (Milian
Suisse SA, Vernier, Switzerland) and slides with 5 μm cryo-
sections of porcine limb muscle were fixed in 3.7% form-
aldehyde or acetone, respectively, for 5 minutes and then
incubated with endothelial specific antibodies: rat anti-pig
CD31 (R&D Systems, Abingdon, United Kingdom), goat
antihuman VE-cadherin (cross-reacting with porcine VE-
cadherin, Santa Cruz Biotechnologies Inc., Dallas, TX), rab-
bit antihumanASGR1 (cross-reactingwith porcineASGR1;20
GenWay Biotech, San Diego, CA), and mouse antihuman Health, Inc. All rights reserved.
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for 2 hours at room temperature or overnight at 4°C. There-
after, slides were washed and exposed to fluorescence conju-
gated secondary antibodies: donkey anti-rat immunoglobulin
(Ig) G Cy3 (Jackson Immunoresearch, West Grove, PA),
donkey anti-goat IgG Alexa 488 (Molecular Probes, Leiden,
The Netherlands), and sheep antirabbit IgG Cy3, (Sigma, St.
Louis, MO). The slides were analyzed using a confocal laser-
scanning microscope (LSM710; Zeiss, Jena, Germany).
In Vitro Human Blood Clotting Assay
The PAEC were cultured on collagen-coated Biosilon
microcarrier beads as described previously by Kohler et al
and Wuensch et al.24,25 Beads with confluent PAEC were in-
cubated with non-anticoagulated whole human blood. For
more details, see SDC, http://links.lww.com/TP/B100).
In Vitro Platelet Phagocytosis—Cell Enzyme-Linked
Immunosorbent Assay
Analysis of human platelet phagocytosis by porcine vas-
cular EC was performed based on the assay described by
Paris et al.20 In brief, 4  107 CFSE-labeled human platelets
were added to wells on 96-well plates containing confluent
EC. For inhibition assay, ECwere preincubated with poly-
clonal rabbit anti-ASGR1 antibody, polyclonal rabbit
IgG as isotype control (Sigma) or asialofetuin (Sigma) for
30 minutes before addition of human platelets. The fluores-
cence of CFSEwas acquired at 492 nm (referencewavelength
517 nm) using a Tecan Infinite M1000 microplate reader.
In Vitro Platelet Phagocytosis—Immunofluorescence
Staining
The CFSE-labeled human platelets, 4  107, were added
to confluent EC on 8-well chamber slides for 60 minutes at
37°C. After fixation, the slides were stained with mouse
anti-pig CD107a (AbD Serotec, Kidlington, Oxford, United
Kingdom), anti-CD31, anti-VE-cadherin, or anti-ASGR1 and
appropriate fluorescence-labeled secondary antibodies. Slides
were analyzed using a Zeiss LSM710 confocal laser-scanning
microscope.
For further details in Materials and Methods, see SDC,
http://links.lww.com/TP/B100.
RESULTS
Ex Vivo Perfusion Model of
Xenotransplantation-Induced Platelet Loss
A rapid loss of circulating human platelets was observed
during xenoperfusion of pig forelimbs with human blood,
whereas in autologous pig blood perfusions only a slow de-
crease of platelet numbers was seen. The average platelet
counts were 236.3 ± 28.9  103/μL in human blood and
301 ± 67.2 103/μL in pig blood. The counts dropped about
2-fold to 102.2 ± 32.9 103/μL and 171.3 ± 26.4 103/μL,
respectively, after the first run through the perfusion system
before getting into contact with porcine tissue. These re-
ductions in platelet counts are explained by the dilution of
the blood with hydroxyethyl starch solution (Voluven,
Fresenius) which was used for priming of the extracorpo-
real circuit. After 10 minutes of xenoperfusion with human
blood, platelet counts dropped approximately 10-fold, from
102.2 ± 32.9  103/μL at the beginning to 13.0 ± 6.1 
103/μL (P = 0.048). In autologous pig blood perfusions, theCopyright © 2015 Wolters Kluwer Hrespective values after 10 minutes were not significantly lower
than at onset (171.3 ± 26.4 103/μL), namely, 122.7 ± 95.5
103/μL, but significantly (P = 0.009) higher than the ones
of the respective xenoperfusions. After 60 minutes of per-
fusion, platelet counts were 11.3 ± 4.1  103/μL in xe-
noperfusions and 94.0 ± 67.4  103/μL in autologous
perfusions, respectively, and stayed at these levels throughout
the remaining perfusion time (720minutes in total, Figure 1).
Platelet counts, measured as area under the curve over the
whole perfusion period, were significantly lower in xenoge-
neic perfusions (P = 0.002, t test) as compared to autolo-
gous perfusions.
ASGR1 Expression by Porcine Vascular
Endothelial Cells
As shown by immunofluorescence and confocal micro-
scopy, cultured PAEC, PFAEC, and PLSEC were positive
for CD31 and ASGR1 (Figure 2A) as well as posi-
tive for VE-cadherin and ASGR1 (Figure S1A, SDC,
http://links.lww.com/TP/B100). Fluorescence intensity of
ASGR1 staining was quantitated using ImageJ software (NIH),
and significance was tested using 1-way analysis of variance
with Bonferroni correction. No difference in ASGR1 expres-
sion was observed between the different types of EC tested
(P > 0.72; Figure S1B, SDC, http://links.lww.com/TP/B100).
Expression of ASGR1 on porcine vascular EC was further
confirmed using flow cytometry. PAEC, PFAEC, and PLSEC
were CD31/ASGR1 double positive for 91.5%, 95.1%, and
94.9% of the total cell numbers, with no difference in
ASGR1 expression levels (Figure 2B to D). The respective
controls were also tested and are represented in Figure 2E
to G. Western blot analysis of whole cell lysates using PAEC,
PFAEC, and PLSEC all showedASGR1 protein expression as
a band at ∼50 kDa (Figure 2H), with no significant differ-
ences in expression levels as analyzed by ImageJ software
(Figure 2I).ASGR1 Protein Expression and Platelet Deposition on
Pig Limb Tissue Samples
Porcine limb muscle (Figure 3A to B) and liver (Figure 3C
to D) tissue samples were all positive for ASGR1 expression
as assessed by immunofluorescence. The fact that staining
for VE-cadherin and CD31, respectively, colocalized with
ASGR1 in all biopsy sections suggests that ASGR1 is in-
deed expressed on endothelial cells, corresponding to the ob-
servations made in vitro using cultured porcine vascular EC.
However, quantitative analysis showed significantly higher
(P < 0.0001) ASGR1 staining on liver tissue as compared to
limb, supposedly due to the known expression of ASGR1
on hepatocytes (Figure 3E).
Muscle tissue biopsies from xenoperfusions were also
analyzed for human platelet infiltration and sequestration
by staining for CD41, a human platelet marker. As shown
in Figures 3F to G, a higher number of human platelets
was found in the muscle tissue after 1 hour of perfusion
(48 ± 11 platelets per high-power viewing field) as compared
with 12 hours of perfusion (1 ± 2, P < 0.0001). Furthermore,
fluorescence microscopy analysis of tissue samples after
1 hour of perfusion showed that sequestered platelets (CD41,
green) were colocalized (yellow) with CD31 (Figure 3H,
white arrows) as well as ASGR1 (red, Figure 3I, whiteealth, Inc. All rights reserved.
696 Transplantation ■ April 2015 ■ Volume 99 ■ Number 4 www.transplantjournal.com
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
© 2015 Wolters Kluwer Bongoni et al 697arrows), indicating binding of platelet aggregates to the en-
dothelium via ASGR1.
Platelet Deposition on PAEC in aMicrocarrier-Based in
Vitro Xenotransplantation Model
PAEC grown on microcarrier beads were incubated with
fresh, non-anticoagulated human blood. The mean clotting
time in the presence of PAEC was significantly prolonged as
compared to microcarrier beads without PAEC (with PAEC,
40.3 ± 8.1 minutes vs 12.8 ± 4.9 minutes without PAEC;
2-tailed t test, P = 0.007). Blood-bead mixture was sampled
after 10 minutes and 20 minutes of incubation and analyzed
for platelet-lymphocyte, platelet-neutrophil, and platelet-
monocyte staining by flow cytometry. Platelet counts dropped
from 277.0 ± 45.1  103/μL at baseline to 119.1 ± 88.4 
103/μL (P < 0.01 vs baseline) after 10 minutes, and
35.0 ± 43.0  103/μL (P < 0.01 vs baseline; P < 0.05 vs
10 minutes) after 20 minutes of incubation. Baseline values
for percentage of white blood cell (WBC)-platelet aggregates
were 12.1% ± 3.8% for lymphocytes, 6.7% ± 3.3% for neu-
trophils, and 18.6% ± 5.3% for monocytes. No significant
changes in CD42a-positive platelet aggregation with lym-
phocytes (15.9%± 14.6% and 16.5%±3.9%) andwith neu-
trophils (14.0% ± 7.3% and 19.3% ± 3.3%) were observed
after 10 and 20 minutes of incubation, respectively. In con-
trast, the percentages of platelet-monocyte aggregates within
the CD14-positive monocyte population were significantly
increased (41.8% ± 6.0% after 10 minutes, and 44.4% ±
3.9% after 20 minutes, for both P < 0.0001 vs baseline)
(Table S1, SDC, http://links.lww.com/TP/B100). In addi-
tion, no statistically significant correlation between reduc-
tion in platelet counts and occurrence of platelet-lymphocyte
(r2 = 0.951, P = 0.142), platelet-neutrophil (r2 = 0.993,
P = 0.053), or platelet-monocyte (r2 = 0.935, P = 0.164) aggre-
gates was observed.
Beads were sampled after 20 minutes of incubation and
analyzed for platelet deposition on PAEC/microcarrier beads.
Immunofluorescence staining of microcarrier beads/PAEC
for the endothelial marker CD31 and for the platelet marker
CD41 showed that CD41-positive platelet deposition was
colocalized with CD31 on microcarrier beads, suggesting
that after 20 minutes of incubation, human platelets adhered
to PAEC (Figure S2, SDC, http://links.lww.com/TP/B100).
Phagocytosis of Carboxyfluorescein Diacetate
Succinimidyl Ester—Labeled Human Platelets by
Porcine Vascular Endothelial Cells
Freshly isolated human platelets were labeled with CFSE
and incubated with cultured PAEC, PFAEC, and PLSEC in
vitro. Within minutes, human platelets bound to all types ofFIGURE 2. Expression of ASGR1 on PAEC, PFAEC, and PLSEC in vitro
row) were analyzed for expression of ASGR1 aswell as the endothelial sp
microscopy. PAEC, PFAEC, and PLSEC were all positive for CD31 and A
dependent experiments is shown. B, PAEC, C, PFAEC, and D, PLSEC w
One representative of 3 independent experiments is shown. E, Represen
CD31 staining on PAEC in the presence of both ASGR1 and CD31 prim
G, ASGR1/CD31 staining on PAEC in the presence of ASGR1 and C3
ASGR1. These controls were used to test non-specific binding. H, West
using PAEC, PLAEC, and PLSEC cultures. Representative data of 3 ind
blot bands of ASGR1/β-actin from whole cell lysates of PAEC, PFAEC a
deviations of 3 high-power viewing fields each of at least 3 independen
were observed as tested by 1-way ANOVA with Bonferroni correction.
Copyright © 2015 Wolters Kluwer HEC, with a peak of fluorescence intensity at 15 minutes.
There was nonstatistically significant difference in fluores-
cence intensity between different types of EC (P ≥ 0.056).
From 30 to 60 minutes, the fluorescence declined to approx-
imately 50% of the maximum (Figure 4A).
As shown by overlay immunofluorescence staining for
CD31 (red), CFSE-labeled human platelets adhered to the
surface of EC after 30 minutes of incubation (Figure 4B).
After 45minutes, however, CFSE-labeled human platelets were
internalized by EC, and colocalization of fluorescence for
ASGR1 and the lysosomal marker CD107a was observed
(Figure 4C).
Inhibition of Platelet Phagocytosis by Blocking of the
ASGR1 Receptor
To confirm involvement of ASGR1 in human platelet
phagocytosis, we examined the effect of blocking the ASGR1
receptor. Preincubation of PAEC, PFAEC, and PLSEC with
polyclonal rabbit anti-ASGR1 antibody led to a significant,
dose-dependent reduction of platelet binding. At 2 μg/mL,
significance levels were P < 0.01, P < 0.05, and P < 0.01 for
PAEC, PFAEC, and PLSEC, respectively. At 5 μg/mL, the
significance of the reduction of platelet binding was P <
0.0001 for all tested EC. Use of a nonspecific isotype control
(polyclonal rabbit IgG) had no effect on platelet binding
(Figure 5A). In addition, asialofetuin, a glycoprotein lacking
terminal sialic acid, was tested as a competitive ligand for
ASGR1 in platelet binding assays. Also, for asialofetuin, a
clear, dose-dependent reduction of platelet binding was ob-
served, with P < 0.01 to < 0.001 for 2 μg/mL and P < 0.001
to < 0.0001 for 5 μg/mL (Figure 5B).
DISCUSSION
During ex vivo xenoperfusion of porcine limbs with hepa-
rinized human blood, human platelets disappeared within
minutes from the circulating blood. This phenomenon is in
line with the observation of xenograft-induced thrombo-
cytopenia and represents a major problem in pig-to-primate
xenotransplantation.8 Transplantation of organs from
α1,3-galactosyltransferasegene-knockout(GalTKO)orGalTKO
and humanCD46 transgenic pigs also led to thrombocytope-
nia throughout the posttransplant period.11 Determination
of the mechanisms responsible for this thrombocytopenia is
necessary for the development of preventive strategies. In this
study, we have shown the expression of ASGR1, a known
platelet binding C-type lectin receptor, in PAEC as well as
PFAEC. In addition to platelet activation and aggregation,
we showed, by specific inhibition using polyclonal anti-
ASGR1 antibody, that human platelet binding and uptake
by PAEC and PFAEC is mediated via ASGR1.. A, Cultured PAEC (upper row), PFAEC (middle row), or PLSEC (lower
ecific marker CD31by immunofluorescence staining and fluorescence
SGR1. Nuclei stained with DAPI. One representative of at least 3 in-
ere analyzed for expression of ASGR1 and CD31 by flow cytometry.
tative image of PAEC only, without any antibody staining. F, ASGR1/
ary antibodies and only the secondary antibody against anti-CD31.
1 primary antibodies but only the secondary antibody against anti-
ern blot analysis of ASGR1 protein and β-actin from whole cell lysate
ependent experiments are shown. I, Quantitative analysis of Western
nd PLSEC by ImageJ software. Shown are mean values ± standard
t experiments. No significant differences in ASGR1 expression levels
ealth, Inc. All rights reserved.
698 Transplantation ■ April 2015 ■ Volume 99 ■ Number 4 www.transplantjournal.comAsialoglycoprotein receptor-1, a component of the Ashwell-
Morell asialoglycoprotein receptor, is located on hepato-
cytes, macrophages, and LSEC, and mediates binding and
removal of circulating glycoproteins carrying Galβ1-4– or
GalNAcβ1-4–terminating epitopes.21,26 AsialoglycoproteinCopyright © 2015 Wolters Kluwerreceptor-1 was previously considered a hepatocyte-specific
protein,27 but has also been shown to occur extrahepatically
in thyroid,28 small and large intestines,29,30, and testis.31 Its
existence in renal proximal tubular epithelial cells has also
been studied,32 whereas it has never been described to occur Health, Inc. All rights reserved.
FIGURE 4. Human platelet phagocytosis and degradation by porcine vascular EC. (A) CFSE-labeled human platelets were incubated with por-
cine vascular EC for different time points as shown on the x axis, followed by detection of CFSE fluorescence intensity on a plate reader. All ECs
were alsomeasured without CFSE-labeled platelets to determine the level of autofluorescence. Data are expressed asmean ± SD of 3 indepen-
dent experiments. (B) Confocal microscopy analysis of CFSE-labeled human platelets by PAEC in vitro. After 30 minutes of incubation, CFSE-
labeled platelets (green fluorescence) adhered to PAEC that were positive for CD31 (red fluorescence). Side views are shown as z panels to the
right of and below the overlay image. (C) Prolonged incubation of CFSE platelets for 45 minutes resulted in internalization into PAEC. Shown are
PAEC stained for ASGR1 (red) and the lysosomal marker CD107a (purple). Side views are shown as z panels to the right and below the overlay
image. In all fluorescence staining experiments, nuclei were stained with DAPI. One representative of 3 independent experiments is shown.
© 2015 Wolters Kluwer Bongoni et al 699on endothelial cells outside the liver. Our data now show that
in addition to LSEC, extrahepatic vascular endothelial cells
also express ASGR1. In vitro, porcine vascular (aortic and
femoral arterial) endothelial cells, characterized by expres-
sion of the endothelial specific markers VE-cadherin and
CD31, were shown to express ASGR1 by immunofluores-
cence staining, flow cytometry, and Western blot. TakenFIGURE 3. ASGR1 expression on biopsy samples from ex vivo perfusio
fusion from the contralateral extremity as baseline samples, and (C and D
dothelial markers (CD31 and VE-cadherin). Results show that ASGR1
CD31 or VE-cadherin, as well as in hepatocytes. Representative data o
ASGR1 staining on limb and liver tissue samples by ImageJ software. Sh
fields each of at least 3 independent experiments. Significance was teste
samples, collected at different xenoperfusion time points, were stained fo
tion. G, CD41-positive human platelet binding and sequestration was hig
xenoperfusion. The amount of platelets was expressed as CD41+ platele
correction (****P ≤ 0.0001). H and I, Staining for colocalization of human
biopsy samples. Human platelets stained with CD41 were colocalized w
Copyright © 2015 Wolters Kluwer Htogether, these assays demonstrate that the ASGR1 protein
is present on PAEC as well as PFAEC.
The asialoglycoprotein receptor is composed of 2 subunits,
amajor subunit (ASGR1) and aminor subunit (ASGR2),33,34
both of which are necessary to form a functional trimer of
2 ASGR1 and 1 ASGR2.35,36 Staining of limb muscle tissue
sections confirmed the presence of ASGR1 in vascularns. A and B, Pig limb skeletal muscle biopsies, collected before per-
) liver tissue samples were stained for expression of ASGR1 and en-
protein is expressed in vascular endothelial cells that are positive for
f 3 independent experiments are shown. E, Quantitative analysis of
own are mean values ± standard deviations of 3 high-power viewing
d using the unpaired 2-tailed Student t test (****P ≤ 0.0001). F, Biopsy
r platelets using anti-CD41 antibody to study binding and sequestra-
h at 1 hour perfusion and then declined to baseline levels at 12 hours
ts per HPF. Significance was tested by 1-way ANOVAwith Bonferroni
platelets with pig CD31 and/or ASGR1 on 1h xenoperfused pig limb
ith porcine (H) CD31 and (I) ASGR1. HPF, high-power viewing field.
ealth, Inc. All rights reserved.
FIGURE 5. Inhibition of human platelet binding and phagocytosis.
PAEC, PFAEC, and PLSEC were preincubated with increasing con-
centrations (0-5 μg/mL) of either (A) rabbit polyclonal anti-ASGR1 an-
tibody or polyclonal rabbit IgG as isotype control, or (B) asialofetuin,
for 30 minutes, followed by incubation with CFSE-labeled human
platelets. After 15 minutes of incubation, human platelet binding
was measured using a fluorescence plate reader. Significance was
tested using one-way ANOVA with Bonferroni correction (*P ≤ 0.05,
**P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001). Data are expressed as
mean ± SD of 3 independent experiments.
700 Transplantation ■ April 2015 ■ Volume 99 ■ Number 4 www.transplantjournal.comendothelial cells. In addition to PLSEC, other liver cells in-
cluding hepatocytes express ASGR1 and thus comparative
analysis showed significantly higher ASGR1 staining on liver
than limb tissue samples. Furthermore, muscle tissue biopsies
from porcine limbs, ex vivo xenoperfused for 1 hour with hu-
man blood, stained positive for CD41, indicating human
platelet sequestration. Staining for CD41 colocalized with
ASGR1 protein, suggesting ASGR1-dependent human plate-
let binding and sequestration.
Platelet activation, aggregation, and phagocytosis can
occur through multiple mechanisms in xenoperfusion or xe-
notransplantation. In addition, platelets have the potential
to influence the immune responses through mechanisms in-
volving endothelial cells and leukocytes. In a recent study,
high amounts of platelet-platelet and platelet-WBC aggre-
gates were found and linked to low apparent platelet
counts.7,11 In the present study, we also observed platelet-
WBC aggregation after 10 and 20 minutes of incubation ofCopyright © 2015 Wolters Kluwerwhole, non-anticoagulated human blood with PAEC grown
onmicrocarrier beads. These data suggest that platelet aggre-
gation with WBC might be a common phenomenon in pig-
to-primate xenotransplantation or xenoperfusion. However,
the reduction in platelet counts showed no statistically sig-
nificant correlation with the percentage of platelet-WBC ag-
gregation. Therefore, other mechanisms, particularly receptor-
mediated adhesion to EC, may contribute to the reduction
in platelet counts. This was supported by detection of co-
localized deposition of CD41-positive platelets with PAEC/
CD31 on microcarrier beads that are covered with a mono-
layer of PAEC, after incubating with human blood. Further-
more, our in vitro results using freshly isolated human
platelets and porcine vascular EC suggest that, at least in
part, receptor-ligand interactions are involved in the clear-
ance of human platelets in vitro and ex vivo in pig-to-
human limb xenotransplantation models.
In vitro, binding of human platelets to EC was observed
and peaked after 15 minutes incubation as reported previ-
ously using PLSEC and CFSE-labeled human platelets.20,21
Thereafter, the CFSE fluorescence elicited by the labeled
platelets gradually declined and at 45 minutes was colocalized
with CD107a, a marker for lysosomes. These findings are in
line with the finding that the receptor forms a complex with
galactose-terminated glycoproteins, which are internalized
and transported to lysosomes, as indicated by colocalized de-
position of CFSE platelets, ASGR1, and CD107a. The recep-
tor and ligand dissociate, and the receptor is recycled back to
the cell surface.37
Asialoglycoprotein receptor-1mediates endocytosis of gly-
coproteins from which the terminal sialic acid residues have
been removed. The presence of higher Galβ1-4 or GalNAcβ1-4
ligand concentrations on human as compared to porcine
platelets may facilitate porcine ASGR1-mediated human
platelet phagocytosis.21 Platelet aggregation and phagocyto-
sis by PLSEC has also been reported in pig-to-baboon liver
xenotransplantation and can be prevented by blocking inte-
grin adhesion pathways.38 Indeed, preincubation of PAEC
with polyclonal anti-ASGR1 antibody significantly reduced
human platelet binding. Also, blocking of ASGR1 using
asialofetuin, a competitive ligand for ASGR1, significantly
reduced platelet uptake by EC in a dose-dependent manner,
supporting involvement of the porcine ASGR1 in human
platelet phagocytosis. Generation of ASGR1 knockout pigs,
with or without introduction of the human ASGR1 and on
top of GalTKO and expression of human regulatory proteins
for complement and coagulation, may therefore help to over-
come the problem of thrombocytopenia in pig-to-human
xenotransplantation.
In conclusion, we found expression of functional ASGR1
in extrahepatic porcine vascular endothelial cells. ASGR1
on the vascular endothelium of porcine organs may therefore
mediate binding and phagocytosis of human platelets during
pig-to-human xenotransplantation.ACKNOWLEDGMENTS
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